Taken together, these results indicate that the IL-33/ST2 axis may regulate the immune function of Th1, CD8+ T cells, and memory T cells, as well as Tregs and MDSCs in the tumor microenvironment of STS. The gene discussed is IL33; the disease is neoplasm.